Ardelyx reported $-10.39M in EBIT for its fiscal quarter ending in June of 2026.





Ebit Change Date
Abbott USD 1.36B 775M Sep/2026
Amgen USD 4.68B 65M Sep/2026
Ardelyx USD -10.39M 20.29M Jun/2026
aTyr Pharma USD -94.72K 26.75K Jun/2026
Corcept Therapeutics USD 114.72M 73.42M Sep/2026
Curis USD -11.52M 3.64M Mar/2026
Sanofi EUR 1.12B 1.06B Jun/2026
TG Therapeutics USD 85.9M 64.22M Sep/2026
United Therapeutics USD 241.3M 134.3M Sep/2026